A Cross-Sectional Study on Medication Treatment Patterns of Bipolar Disorder in China
司天梅,舒良,于欣,马崔,王高华,白培深,刘协和,纪丽萍,师建国,陈宪生,梅其一,栗克清,张鸿燕,马弘
DOI: https://doi.org/10.3760/j:issn:1006-7884.2005.03.011
2005-01-01
Abstract:Objective To uncover the medication treatment patterns of bipolar disorder in China.Methods With the same sampling ratio, 46 hospitals from 10 provinces and cities were surveyed during 20th— 24th, May 2002, using the retested and revised self-made questionnaire.Results The total number of sample was 558, including 472 patients with bipolar mania and 86 with bipolar depression, and 555 cases were treated with psychotropic drugs. Medication most frequently prescribed was mood stabilizers (80.7%). And 404 cases (72.8%) were treated with antipsychotic agents. Compared with outpatients, inpatients had more chance of receiving antipsychotic agents. Patients with bipolar mania were treated mainly with mood stabilizers (84.7%) and antipsychotic agents (81.4%), or combination of both. Most patients with bipolar depression (80.2%) were treated with the antidepressants. And most of the patients (80.2%) were treated with polypharmacy. Main factors affecting medication pattern was the patient′s clinical features. One forth of the patients (145) was given combinative treatment of benzodiazepines, mainly as the augmentation.Conclusion Medication prescription pattern for patients with bipolar disorder in China is in principle adherent to published practice guidelines. High rate of antidepressants used in bipolar depression remains to be assessed in clinical practice in future.
What problem does this paper attempt to address?